When was Qureator founded?

Qureator was founded in 2020 and raised its 1st funding round 5 years after it was founded.

Where is Qureator located?

Qureator is headquartered in San Diego, United States.

How many employees does Qureator have?

As of Apr 30, 2026, the latest employee count at Qureator is 25.

Is Qureator a funded company?

Qureator is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Dec 23, 2025.

When was the latest funding round of Qureator?

Qureator's latest funding was a $***** Series A round on Dec 23, 2025, with participation from 0 investor.

Where does Qureator rank among its competitors?

Qureator ranks 16th amongst 40 active competitors, of which 18 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Qureator, which secured $6.68M in Dec, 2025.

Who are the top competitors of Qureator?

Qureator's top competitors include CN Bio, Emulate and Hesperos. Among them, Qureator secured the most recent funding round in December, 2025.

Qureator - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of micro physiological systems for drug discovery. It offers Curiochips designed for recapitulating the complexity of tissue microenvironments for microscale 3D cell culture conditions for a variety of applications in biomedical research.

Website: qureator.com
Email ID: *****@qureator.com
Phone Number: +82 **********

Key Metrics

Founded Year

2020

Location

San Diego, United States

Stage

Series A

Total Funding

$6.68M in 1 round

Latest Funding Round

Series A, Dec 23, 2025, $*****

Ranked

16^th among 40 active competitors

Employee Count

25 as on Apr 30, 2026

Similar Companies

CN Bio & 39 more

View Qureator's full profile

Qureator has raised a total funding of $6.68M over 1 round.

Here is the list of recent funding rounds of Qureator:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 23, 2025	6370711	Series A	9074247	7009277	1492078	5988363

Access funding benchmarks and valuations. Sign up today!

View details of Qureator's funding rounds and investors

Qureator's employee count trend

Qureator has 25 employees as of Apr 26. Here is Qureator's employee count trend over the years:

Uncover Qureator's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Qureator include CN Bio, Emulate and Hesperos. Here is the list of Top 10 competitors of Qureator, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CN Bio 2009, Cambridge (United Kingdom), Series B	Develops organ-on-a-chip platforms for drug discovery	$44.8M	CITIC, Oxford University Innovation & 16 others	62/100
2nd	Emulate 2013, Boston (United States), Series E	Developer of in vitro models for drug development	$225M	ND Capital, Cedars Sinai & 24 others	59/100
3rd	Hesperos 2015, Orlando (United States), Funding Raised	Developer of organ-on-a-chip solutions for preclinical testing	-	HHS, NCATS	54/100
4th	Okomera 2020, Paris (France), Seed	Developer of a device for in vitro cancer testing using a microfluidic chip	$11.2M	Resonance, Berkeley SkyDeck Fund & 4 others	52/100
5th	Nortis 2007, Woodinville (United States), Acquired	Developer of platform for generating small segments of human tissues and organs in microfluidic chips	$10.7M	SeaChange Fund, Vertical Venture Partners ... & 3 others	50/100
6th	Cellbox Labs 2020, Riga (Latvia), Seed	Provider of organ-on-chip platform for drug discovery and development	$1.01M	Buildit, ASP Asset Management. & 5 others	47/100
7th	Obatala Sciences 2017, New Orleans (United States), Series A	Provider of research enabling products and services to research centers	$3.53M	Ochsner, Ochsner Lafayette General & 9 others	47/100
8th	Mimetas 2013, Leiden (Netherlands), Series B	Develops microfluidics-based organ-on-a-chip tissue models	$28.9M	Zeeuws Investerings Fonds, Oost NL & 13 others	45/100
9th	Kirkstall 2006, York (United Kingdom), Seed	Developer of an advanced in vitro systems that mimic human physiology for research	$848K	Braveheart Investment Group, South Yorkshire Investment Fund ... & 13 others	40/100
10th	Mepsgen 2019, Seoul (South Korea), Series C	Developer of human organ model chips for pharmaceutical development	$29.3M	E&Investment, KB Investment & 6 others	39/100
16th	Qureator 2020, San Diego (United States), Series A	Developer of micro physiological systems for drug discovery	$6.68M	-	33/100